D-1126-2023 Class II Terminated
FDA drug recall D-1126-2023 was initiated by Central Admixture Pharmacy Services, Inc. on Aug 17, 2023 and is designated Class II. Reason for recall: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles The recall status is terminated (terminated Mar 27, 2025). Affected quantity: 297 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 6, 2023
- Initiation Date
- Aug 17, 2023
- Termination Date
- Mar 27, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 297 bags
Product Description
PHENYLephrine added to 0.9% sodium chloride, 20mg/250ml (80 mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-7025-1.
Reason for Recall
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Distribution Pattern
Nationwide in the USA
Code Information
Lot# 36-260037, Exp 10/3/2023. ;
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1126-2023
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026